Literature DB >> 28880368

Optimization of Monte Carlo particle transport parameters and validation of a novel high throughput experimental setup to measure the biological effects of particle beams.

Darshana Patel1, Lawrence Bronk2, Fada Guan1, Christopher R Peeler1, Stephan Brons3, Ivana Dokic3,4, Amir Abdollahi3,4, Claudia Rittmüller3, Oliver Jäkel3, David Grosshans2,5, Radhe Mohan1, Uwe Titt1.   

Abstract

PURPOSE: Accurate modeling of the relative biological effectiveness (RBE) of particle beams requires increased systematic in vitro studies with human cell lines with care towards minimizing uncertainties in biologic assays as well as physical parameters. In this study, we describe a novel high-throughput experimental setup and an optimized parameterization of the Monte Carlo (MC) simulation technique that is universally applicable for accurate determination of RBE of clinical ion beams. Clonogenic cell-survival measurements on a human lung cancer cell line (H460) are presented using proton irradiation.
METHODS: Experiments were performed at the Heidelberg Ion Therapy Center (HIT) with support from the Deutsches Krebsforschungszentrum (DKFZ) in Heidelberg, Germany using a mono-energetic horizontal proton beam. A custom-made variable range selector was designed for the horizontal beam line using the Geant4 MC toolkit. This unique setup enabled a high-throughput clonogenic assay investigation of multiple, well defined dose and linear energy transfer (LETs) per irradiation for human lung cancer cells (H460) cultured in a 96-well plate. Sensitivity studies based on application of different physics lists in conjunction with different electromagnetic constructors and production threshold values to the MC simulations were undertaken for accurate assessment of the calculated dose and the dose-averaged LET (LETd ). These studies were extended to helium and carbon ion beams.
RESULTS: Sensitivity analysis of the MC parameterization revealed substantial dependence of the dose and LETd values on both the choice of physics list and the production threshold values. While the dose and LETd calculations using FTFP_BERT_LIV, FTFP_BERT_EMZ, FTFP_BERT_PEN and QGSP_BIC_EMY physics lists agree well with each other for all three ions, they show large differences when compared to the FTFP_BERT physics list with the default electromagnetic constructor. For carbon ions, the dose corresponding to the largest LETd value is observed to differ by as much as 78% between FTFP_BERT and FTFP_BERT_LIV. Furthermore, between the production threshold of 700 μm and 5 μm, proton dose varies by as much as 19% corresponding to the largest LETd value sampled in the current investigation. Based on the sensitivity studies, the FTFP_BERT physics list with the low energy Livermore electromagnetic constructor and a production threshold of 5 μm was employed for determining accurate dose and LETd . The optimized MC parameterization results in a different LETd dependence of the RBE curve for 10% SF of the H460 cell line irradiated with proton beam when compared with the results from a previous study using the same cell line. When the MC parameters are kept consistent between the studies, the proton RBE results agree well with each other within the experimental uncertainties.
CONCLUSIONS: A custom high-throughput, high-accuracy experimental design for accurate in vitro cell survival measurements was employed at a horizontal beam line. High sensitivity of the physics-based optimization establishes the importance of accurate MC parameterization and hence the conditioning of the MC system on a case-by-case basis. The proton RBE results from current investigations are observed to agree with a previous measurement made under different experimental conditions. This establishes the consistency of our experimental findings across different experiments and institutions.
© 2017 American Association of Physicists in Medicine.

Entities:  

Keywords:  Monte Carlo simulations; high throughput experiments; protons; relative biological effectiveness

Mesh:

Year:  2017        PMID: 28880368     DOI: 10.1002/mp.12568

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  5 in total

1.  Using the Proton Energy Spectrum and Microdosimetry to Model Proton Relative Biological Effectiveness.

Authors:  Mark Newpower; Darshana Patel; Lawrence Bronk; Fada Guan; Pankaj Chaudhary; Stephen J McMahon; Kevin M Prise; Giuseppe Schettino; David R Grosshans; Radhe Mohan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-02-05       Impact factor: 7.038

2.  Combined effects of cisplatin and photon or proton irradiation in cultured cells: radiosensitization, patterns of cell death and cell cycle distribution.

Authors:  Hiromitsu Iwata; Tsuyoshi Shuto; Shunsuke Kamei; Kohei Omachi; Masataka Moriuchi; Chihiro Omachi; Toshiyuki Toshito; Shingo Hashimoto; Koichiro Nakajima; Chikao Sugie; Hiroyuki Ogino; Hirofumi Kai; Yuta Shibamoto
Journal:  J Radiat Res       Date:  2020-11-16       Impact factor: 2.724

3.  Physical parameter optimization scheme for radiobiological studies of charged particle therapy.

Authors:  Changran Geng; Drake Gates; Lawrence Bronk; Duo Ma; Fada Guan
Journal:  Phys Med       Date:  2018-06-14       Impact factor: 2.685

4.  Research Facility for Radiobiological Studies at the University Proton Therapy Dresden.

Authors:  Elke Beyreuther; Michael Baumann; Wolfgang Enghardt; Stephan Helmbrecht; Leonhard Karsch; Mechthild Krause; Jörg Pawelke; Lena Schreiner; Michael Schürer; Cläre von Neubeck; Armin Lühr
Journal:  Int J Part Ther       Date:  2018-09-21

5.  Mapping the Relative Biological Effectiveness of Proton, Helium and Carbon Ions with High-Throughput Techniques.

Authors:  Lawrence Bronk; Fada Guan; Darshana Patel; Duo Ma; Benjamin Kroger; Xiaochun Wang; Kevin Tran; Joycelyn Yiu; Clifford Stephan; Jürgen Debus; Amir Abdollahi; Oliver Jäkel; Radhe Mohan; Uwe Titt; David R Grosshans
Journal:  Cancers (Basel)       Date:  2020-12-05       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.